将医疗补助登记死亡数据与缅因州全州死亡记录进行比较
Katherine A Ahrens1, Apsara Kumarage2, Philip Dubois3
1Public Health Program, Muskie School of Public Service, University of Southern Maine, Portland, Maine.
Journal of evaluation in clinical practice
|March 11, 2025
概括
医疗补助死亡数据通常与州记录一致,但只有死亡证明的联系揭示了死亡原因,这对于监测阿片类药物使用障碍 (OUD) 服务至关重要.
科学领域:
- 公共卫生 公共卫生
- 医疗保健服务研究 医疗服务研究
- 流行病学 流行病学
背景情况:
- 医疗补助入学数据可能有不完整的死亡信息.
- 死亡原因通常在医疗补助记录中缺失.
- 这项研究将医疗补助登记死亡数据与缅因州的州死亡记录进行比较.
研究的目的:
- 从入学数据中比较医疗补助注册人死亡日期与死亡证明链接 (2016-2023年).
- 根据阿片类药物使用障碍 (OUD) 状态,分析2023年药物过量死亡的风险.
- 支持新的医疗补助服务提供方法的监测活动.
主要方法:
- 利用了缅因州的医疗补助入学 (2010-2023) 和索赔 (2016-2023) 数据.
- 合并的缅因州死亡证明数据 (2016-2023年,含2024年临时数据).
- 将死亡证明与医疗补助数据联系起来,以根据非老年成年人OUD状态来确定过量死亡风险.
主要成果:
- 死亡人数在医疗补助入学数据和死亡证明联系 (90%的重叠) 之间基本一致.
- 死亡证明链接每年在入学者中发现的死亡人数略有增加.
- 在2023年,OUD患者的药物过量死亡风险是OUD患者 (0.68%) 的6.1倍,而没有OUD患者 (0.11%) 的风险是6.1倍.
结论:
- 医疗补助入学数据和死亡记录之间存在关于死亡日期的良好一致性.
- 持续的死亡证明-医疗补助链接对于检查死亡原因至关重要.
- 这种联系对于监测缅因州新的医疗补助服务提供模式至关重要,特别是在OUD方面.
相关概念视频
01:22Life Tables
65
A life table is a statistical tool that summarizes the mortality and survival patterns of a population, providing detailed insights into the likelihood of survival or death across different age intervals within a cohort. By organizing data on survival probabilities and mortality rates, life tables offer a clear snapshot of population dynamics over time. They are extensively used in demography, public health, actuarial science, and ecology to analyze life expectancy, design health interventions,...
65
01:29Documentation in Long-Term and Home Healthcare Setting
868
Documentation in long-term care facilities and home healthcare settings is crucial for ensuring continuous, coordinated, and comprehensive care for patients. Each setting has its specific documentation processes and tools:
Long-Term Care Facilities
Long-Term Care Facilities
868
01:20Actuarial Approach
50
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
50
01:22Applications of Life Tables
41
Life tables are versatile across various fields, providing a quantitative basis for analyzing mortality and survival rates. Whether used by demographers, actuaries, epidemiologists, or sociologists, life tables offer valuable insights into the dynamics of life and death, facilitating informed decisions in public health, insurance, conservation, and beyond. Their broad applicability highlights the interconnectedness of demographic data with practical outcomes in everyday life and strategic...
41
01:20Comparing the Survival Analysis of Two or More Groups
115
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
115
01:24Kaplan-Meier Approach
74
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
74